In connective tissue diseases like SLE and RA, CXCL12 facilitates the migration of immune cells to inflammatory sites, while CCL5 amplifies the recruitment of T cells and monocytes, promoting chronic inflammation and tissue damage. Here, CCL5 is linked to connective tissue disorder.